The WACC of Supernus Pharmaceuticals Inc (SUPN) is 7.6%.
| Range | Selected | |
| Cost of equity | 7.70% - 9.80% | 8.75% |
| Tax rate | 22.30% - 23.90% | 23.10% |
| Cost of debt | 4.00% - 4.90% | 4.45% |
| WACC | 6.7% - 8.5% | 7.6% |
| Category | Low | High |
| Long-term bond rate | 4.2% | 4.7% |
| Equity market risk premium | 5.0% | 6.0% |
| Adjusted beta | 0.7 | 0.77 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.70% | 9.80% |
| Tax rate | 22.30% | 23.90% |
| Debt/Equity ratio | 0.27 | 0.27 |
| Cost of debt | 4.00% | 4.90% |
| After-tax WACC | 6.7% | 8.5% |
| Selected WACC | 7.6% | |